Literature DB >> 10712202

Decreased elastin deposition and high proliferation of fibroblasts from Costello syndrome are related to functional deficiency in the 67-kD elastin-binding protein.

A Hinek1, A C Smith, E M Cutiongco, J W Callahan, K W Gripp, R Weksberg.   

Abstract

Costello syndrome is characterized by mental retardation, loose skin, coarse face, skeletal deformations, cardiomyopathy, and predisposition to numerous malignancies. The genetic origin of Costello syndrome has not yet been defined. Using immunohistochemistry and metabolic labeling with [3H]-valine, we have established that cultured skin fibroblasts obtained from patients with Costello syndrome did not assemble elastic fibers, despite an adequate synthesis of tropoelastin and normal deposition of the microfibrillar scaffold. We found that impaired production of elastic fibers by these fibroblasts is associated with a functional deficiency of the 67-kD elastin-binding protein (EBP), which is normally required to chaperone tropoelastin through the secretory pathways and to its extracellular assembly. Metabolic pulse labeling of the 67-kD EBP with radioactive serine and further chase of this tracer indicated that both normal fibroblasts and fibroblasts from patients with Costello syndrome initially synthesized comparable amounts of this protein; however, the fibroblasts from Costello syndrome patients quickly lost it into the conditioned media. Because the normal association between EBP and tropoelastin can be disrupted on contact with galactosugar-bearing moieties, and the fibroblasts from patients with Costello syndrome revealed an unusual accumulation of chondroitin sulfate-bearing proteoglycans (CD44 and biglycan), we postulate that a chondroitin sulfate may be responsible for shedding EBP from Costello cells and in turn for their impaired elastogenesis. This was further supported by the fact that exposure to chondroitinase ABC, an enzyme capable of chondroitin sulfate degradation, restored normal production of elastic fibers by fibroblasts from patients with Costello syndrome. We also present evidence that loss of EBP from fibroblasts of Costello syndrome patients is associated with an unusually high rate of cellular proliferation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10712202      PMCID: PMC1288169          DOI: 10.1086/302829

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  66 in total

Review 1.  Costello syndrome: phenotype, natural history, differential diagnosis, and possible cause.

Authors:  J P Johnson; M Golabi; M E Norton; R M Rosenblatt; G M Feldman; S P Yang; B D Hall; M H Fries; J C Carey
Journal:  J Pediatr       Date:  1998-09       Impact factor: 4.406

Review 2.  Forms and functions of CD44.

Authors:  G Borland; J A Ross; K Guy
Journal:  Immunology       Date:  1998-02       Impact factor: 7.397

Review 3.  The CD44 protein family.

Authors:  H Ponta; D Wainwright; P Herrlich
Journal:  Int J Biochem Cell Biol       Date:  1998-03       Impact factor: 5.085

Review 4.  Cardiac disease in Costello syndrome.

Authors:  E S Siwik; K G Zahka; G L Wiesner; C Limwongse
Journal:  Pediatrics       Date:  1998-04       Impact factor: 7.124

5.  Costello syndrome with acoustic neuroma and cataract. Is the Costello locus linked to neurofibromatosis type 2 on 22q?

Authors:  M Suri; C Garrett
Journal:  Clin Dysmorphol       Date:  1998-04       Impact factor: 0.816

Review 6.  Costello syndrome.

Authors:  N Philip; S Sigaudy
Journal:  J Med Genet       Date:  1998-03       Impact factor: 6.318

7.  Elastin is an essential determinant of arterial morphogenesis.

Authors:  D Y Li; B Brooke; E C Davis; R P Mecham; L K Sorensen; B B Boak; E Eichwald; M T Keating
Journal:  Nature       Date:  1998-05-21       Impact factor: 49.962

8.  Tropoelastin and elastin degradation products promote proliferation of human astrocytoma cell lines.

Authors:  S Jung; J T Rutka; A Hinek
Journal:  J Neuropathol Exp Neurol       Date:  1998-05       Impact factor: 3.685

Review 9.  Elastic fiber during development and aging.

Authors:  I Pasquali-Ronchetti; M Baccarani-Contri
Journal:  Microsc Res Tech       Date:  1997-08-15       Impact factor: 2.769

10.  The 67-kDa enzymatically inactive alternatively spliced variant of beta-galactosidase is identical to the elastin/laminin-binding protein.

Authors:  S Privitera; C A Prody; J W Callahan; A Hinek
Journal:  J Biol Chem       Date:  1998-03-13       Impact factor: 5.157

View more
  30 in total

1.  Elastic-fiber pathologies: primary defects in assembly-and secondary disorders in transport and delivery.

Authors:  Z Urbán; C D Boyd
Journal:  Am J Hum Genet       Date:  2000-06-06       Impact factor: 11.025

2.  C4ST-1/CHST11-controlled chondroitin sulfation interferes with oncogenic HRAS signaling in Costello syndrome.

Authors:  Michael Klüppel; Payman Samavarchi-Tehrani; Kela Liu; Jeffrey L Wrana; Aleksander Hinek
Journal:  Eur J Hum Genet       Date:  2012-02-08       Impact factor: 4.246

3.  Retinoblastoma protein modulates the inverse relationship between cellular proliferation and elastogenesis.

Authors:  Sanjana Sen; Severa Bunda; Junyan Shi; Andrew Wang; Thomas F Mitts; Aleksander Hinek
Journal:  J Biol Chem       Date:  2011-08-31       Impact factor: 5.157

4.  Neointima formed by arterial smooth muscle cells expressing versican variant V3 is resistant to lipid and macrophage accumulation.

Authors:  Mervyn J Merrilees; Brent W Beaumont; Kathleen R Braun; Anita C Thomas; Inkyung Kang; Aleksander Hinek; Alberto Passi; Thomas N Wight
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-03-24       Impact factor: 8.311

Review 5.  Where catabolism meets signalling: neuraminidase 1 as a modulator of cell receptors.

Authors:  Alexey V Pshezhetsky; Aleksander Hinek
Journal:  Glycoconj J       Date:  2011-09-20       Impact factor: 2.916

6.  Inhibition of versican expression by siRNA facilitates tropoelastin synthesis and elastic fiber formation by human SK-LMS-1 leiomyosarcoma smooth muscle cells in vitro and in vivo.

Authors:  Paul A Keire; Steven L Bressler; Eileen R Mulvihill; Barry C Starcher; Inkyung Kang; Thomas N Wight
Journal:  Matrix Biol       Date:  2015-12-23       Impact factor: 11.583

7.  Modulating action of the new polymorphism L436F detected in the GLB1 gene of a type-II GM1 gangliosidosis patient.

Authors:  Anna Caciotti; Tiziana Bardelli; John Cunningham; Alessandra D'Azzo; Enrico Zammarchi; Amelia Morrone
Journal:  Hum Genet       Date:  2003-03-19       Impact factor: 4.132

8.  Fibulin-4 regulates expression of the tropoelastin gene and consequent elastic-fibre formation by human fibroblasts.

Authors:  Qiuyun Chen; Teng Zhang; Joseph F Roshetsky; Zhufeng Ouyang; Jeroen Essers; Chun Fan; Qing Wang; Aleksander Hinek; Edward F Plow; Paul E Dicorleto
Journal:  Biochem J       Date:  2009-09-14       Impact factor: 3.857

9.  Advances in biomimetic regeneration of elastic matrix structures.

Authors:  Balakrishnan Sivaraman; Chris A Bashur; Anand Ramamurthi
Journal:  Drug Deliv Transl Res       Date:  2012-10       Impact factor: 4.617

10.  VE-statin/egfl7 regulates vascular elastogenesis by interacting with lysyl oxidases.

Authors:  Etienne Lelièvre; Aleksander Hinek; Florea Lupu; Christelle Buquet; Fabrice Soncin; Virginie Mattot
Journal:  EMBO J       Date:  2008-05-22       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.